CalciMedica is trading at $2.14 (+6.98%) after Nasdaq closed its market-value compliance matter on September 2, 2026, following the company’s satisfaction of the alternative stockholders’ equity requirement.
- The announcement reduces immediate delisting concerns and follows the recent 1-for-5 reverse split intended to restore minimum-bid-price compliance.
- Shares remain highly volatile, rising 360.81% on August 31 and falling 6.54% on September 1.